Liberating the data from clinical trials

@article{Henry2015LiberatingTD,
  title={Liberating the data from clinical trials},
  author={David Henry and T. Fitzpatrick},
  journal={BMJ : British Medical Journal},
  year={2015},
  volume={351}
}
  • David Henry, T. Fitzpatrick
  • Published 2015
  • Medicine
  • BMJ : British Medical Journal
    • Liberated trial data have enduring potential to benefit patients, prevent harm, and correct misleading research 
    View on BMJ
    ncbi.nlm.nih.gov
    16 Citations
    Background Citations
    3
    16 Citations
    Citation Type

    Citation Type

    Benefits of, and barriers to, reactivating dormant trials
    • 1
    • PDF
    Data sharing is desirable, but benefits should not be exaggerated
    • 1
    Novel trial strategies to enhance the relevance, efficiency, effectiveness and impact of nephrology research.
    • 1
    Assessment of Long-term Follow-up of Randomized Trial Participants by Linkage to Routinely Collected Data
    • 6
    • PDF
    Gynaecologists and industry: ain't no sunshine.
    • 9
    • PDF
    Protocol for a scoping review of post-trial extensions of randomised controlled trials using individually linked administrative and registry data
    • 3
    • PDF
    Inauguration of the Journal of Emergency and Critical Care Medicine
    Antidepressants: Conundrums and Complexities of Efficacy Studies
    • R. Pies
    • Medicine
    • Journal of clinical psychopharmacology
    • 2016
    • 10
    The History, Advocacy and Efficacy of Data Management Plans
    • 6
    • PDF
    If you build it, they will come: unintended future uses of organised health data collections
    • 32

    References

    SHOWING 1-10 OF 24 REFERENCES
    The BMJ requires data sharing on request for all trials
    • 53
    • PDF
    All trials must be registered and the results published
    • 117
    • PDF
    Restoring invisible and abandoned trials: a call for people to publish the findings
    • 147
    • PDF
    Sharing clinical trial data: maximizing benefits, minimizing risk.
    • 255
    • PDF
    No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility
    • P. Doshi
    • Medicine
    • BMJ : British Medical Journal
    • 2015
    • 19
    Reanalyses of randomized clinical trial data.
    • 135
    • PDF
    Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
    • 206
    • PDF
    Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial.
    • 212
    • PDF
    Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial
    • 515
    • PDF
    Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study
    • 35
    • PDF